Challenging dogmas
Drug provocation tests (DPT) are considered the gold standard procedure to ascertain the diagnosis of beta-lactam (BL) allergy. Regarding route of administration, current recommendations prioritize oral challenges, considering them safer, and reserving the intravenous route for drugs for which this...
| Autores: | , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:ddd.uab.cat:294065 |
| Acceso en línea: | https://ddd.uab.cat/record/294065 https://dx.doi.org/urn:doi:10.1016/j.waojou.2024.100914 |
| Access Level: | acceso abierto |
| Palabra clave: | Drug provocation test Beta-lactam Intravenous drug provocation test Oral drug provocation test Drug hypersensitivity reaction |
| id |
ES_c552a0989c2b2d1071eab768f083d6d3 |
|---|---|
| oai_identifier_str |
oai:ddd.uab.cat:294065 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Challenging dogmasIntravenous versus oral beta-lactam antibiotic provocation testsMolina-Molina, Gustavo-Jorge|||0000-0002-3577-8512Gómez-Duque, ManuelVidal Guitart, Xavier|||0000-0001-6705-4298Agustí Escasany, AntòniaLabrador Horrillo, Moises|||0000-0003-3222-2380Luengo Sánchez, Olga|||0000-0002-8905-2776Sala-Cunill, Anna|||0000-0002-2178-1067Galván Blasco, Paula|||0000-0003-3006-3160Guilarte, Mar|||0000-0001-7242-9584Cardona, Victoria|||0000-0003-2197-9767Drug provocation testBeta-lactamIntravenous drug provocation testOral drug provocation testDrug hypersensitivity reactionDrug provocation tests (DPT) are considered the gold standard procedure to ascertain the diagnosis of beta-lactam (BL) allergy. Regarding route of administration, current recommendations prioritize oral challenges, considering them safer, and reserving the intravenous route for drugs for which this is the only formulation. To compare in terms of tolerance and safety two protocols of BL DPT, using an oral protocol (OR-DPT) and an intravenous protocol (IV-DPT). A descriptive, retrospective study was performed, including adult patients who underwent IV-DPT or OR-DPT for suspected immediate or delayed hypersensitivity to BL antibiotics, over a period of 4 years (between January 2018 and December 2021). Demographical data, index hypersensivity reactions' characteristics and tolerance to DPT were reviewed. A total of 1036 patients underwent DPT, mean age of 56.8 (standard deviation, SD, 17.8) years, 655 were women (63.2%). Immediate drug hypersensitivity reactions (DHR) had occurred in 564 of patients (54.4%). OR-DPT were performed in 439 (42.4%) and IV-DPT in 597 (57.6%). The frequency of reactions during DPT, regardless of the route used, was low (3.6%): only 16 (3.6%) in OR-DPT and 21 (3.5%) in IV-DPT. From IV-DPT, 16 out 21 DHR during DPT were immediate compared with 4 out of 16 in OR-DPT. Adjusted relative risk of developing a hypersensitivity reaction during IV-DPT versus OR-DPT was 1.13 (95% confidence interval (CI)0.57-2.22). The results suggest that OR-DPT and IV-DPT are both safe procedures when adequately performed. However, IV-DPT protocols showed a higher rate of immediate DHR during DPT probably due to the selection of basal high-risk patients to undergo IV-DPT. In conclusion, IV-DPT may be considered as an option for challenges in drug-allergy studies, entailing a precise administration. 22024-01-0120242024-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/294065https://dx.doi.org/urn:doi:10.1016/j.waojou.2024.100914reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2940652026-06-06T12:50:31Z |
| dc.title.none.fl_str_mv |
Challenging dogmas Intravenous versus oral beta-lactam antibiotic provocation tests |
| title |
Challenging dogmas |
| spellingShingle |
Challenging dogmas Molina-Molina, Gustavo-Jorge|||0000-0002-3577-8512 Drug provocation test Beta-lactam Intravenous drug provocation test Oral drug provocation test Drug hypersensitivity reaction |
| title_short |
Challenging dogmas |
| title_full |
Challenging dogmas |
| title_fullStr |
Challenging dogmas |
| title_full_unstemmed |
Challenging dogmas |
| title_sort |
Challenging dogmas |
| dc.creator.none.fl_str_mv |
Molina-Molina, Gustavo-Jorge|||0000-0002-3577-8512 Gómez-Duque, Manuel Vidal Guitart, Xavier|||0000-0001-6705-4298 Agustí Escasany, Antònia Labrador Horrillo, Moises|||0000-0003-3222-2380 Luengo Sánchez, Olga|||0000-0002-8905-2776 Sala-Cunill, Anna|||0000-0002-2178-1067 Galván Blasco, Paula|||0000-0003-3006-3160 Guilarte, Mar|||0000-0001-7242-9584 Cardona, Victoria|||0000-0003-2197-9767 |
| author |
Molina-Molina, Gustavo-Jorge|||0000-0002-3577-8512 |
| author_facet |
Molina-Molina, Gustavo-Jorge|||0000-0002-3577-8512 Gómez-Duque, Manuel Vidal Guitart, Xavier|||0000-0001-6705-4298 Agustí Escasany, Antònia Labrador Horrillo, Moises|||0000-0003-3222-2380 Luengo Sánchez, Olga|||0000-0002-8905-2776 Sala-Cunill, Anna|||0000-0002-2178-1067 Galván Blasco, Paula|||0000-0003-3006-3160 Guilarte, Mar|||0000-0001-7242-9584 Cardona, Victoria|||0000-0003-2197-9767 |
| author_role |
author |
| author2 |
Gómez-Duque, Manuel Vidal Guitart, Xavier|||0000-0001-6705-4298 Agustí Escasany, Antònia Labrador Horrillo, Moises|||0000-0003-3222-2380 Luengo Sánchez, Olga|||0000-0002-8905-2776 Sala-Cunill, Anna|||0000-0002-2178-1067 Galván Blasco, Paula|||0000-0003-3006-3160 Guilarte, Mar|||0000-0001-7242-9584 Cardona, Victoria|||0000-0003-2197-9767 |
| author2_role |
author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Drug provocation test Beta-lactam Intravenous drug provocation test Oral drug provocation test Drug hypersensitivity reaction |
| topic |
Drug provocation test Beta-lactam Intravenous drug provocation test Oral drug provocation test Drug hypersensitivity reaction |
| description |
Drug provocation tests (DPT) are considered the gold standard procedure to ascertain the diagnosis of beta-lactam (BL) allergy. Regarding route of administration, current recommendations prioritize oral challenges, considering them safer, and reserving the intravenous route for drugs for which this is the only formulation. To compare in terms of tolerance and safety two protocols of BL DPT, using an oral protocol (OR-DPT) and an intravenous protocol (IV-DPT). A descriptive, retrospective study was performed, including adult patients who underwent IV-DPT or OR-DPT for suspected immediate or delayed hypersensitivity to BL antibiotics, over a period of 4 years (between January 2018 and December 2021). Demographical data, index hypersensivity reactions' characteristics and tolerance to DPT were reviewed. A total of 1036 patients underwent DPT, mean age of 56.8 (standard deviation, SD, 17.8) years, 655 were women (63.2%). Immediate drug hypersensitivity reactions (DHR) had occurred in 564 of patients (54.4%). OR-DPT were performed in 439 (42.4%) and IV-DPT in 597 (57.6%). The frequency of reactions during DPT, regardless of the route used, was low (3.6%): only 16 (3.6%) in OR-DPT and 21 (3.5%) in IV-DPT. From IV-DPT, 16 out 21 DHR during DPT were immediate compared with 4 out of 16 in OR-DPT. Adjusted relative risk of developing a hypersensitivity reaction during IV-DPT versus OR-DPT was 1.13 (95% confidence interval (CI)0.57-2.22). The results suggest that OR-DPT and IV-DPT are both safe procedures when adequately performed. However, IV-DPT protocols showed a higher rate of immediate DHR during DPT probably due to the selection of basal high-risk patients to undergo IV-DPT. In conclusion, IV-DPT may be considered as an option for challenges in drug-allergy studies, entailing a precise administration. |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2 2024-01-01 2024 2024-01-01 |
| dc.type.none.fl_str_mv |
Article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://ddd.uab.cat/record/294065 https://dx.doi.org/urn:doi:10.1016/j.waojou.2024.100914 |
| url |
https://ddd.uab.cat/record/294065 https://dx.doi.org/urn:doi:10.1016/j.waojou.2024.100914 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Dipòsit Digital de Documents de la UAB instname:Universitat Autònoma de Barcelona |
| instname_str |
Universitat Autònoma de Barcelona |
| reponame_str |
Dipòsit Digital de Documents de la UAB |
| collection |
Dipòsit Digital de Documents de la UAB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869418978435137536 |
| score |
15.812429 |